Atherosclerosis, an inflammatory and fibroproliferative disease. A prophylactic phytochemical approach with Ginkgo biloba (EGb 761)

Atherosclerosis

Volumn 195, Issue 2, 2007, Pages 419-422

  Schafer P ^a   Rodriguez M ^a   Siegel, G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atherosclerosis; Ginkgo biloba; Inflammation; Lipoprotein(a); Metabolic syndrome; ROS status

Indexed keywords

GELATINASE B; GINKGO BILOBA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DRUG MECHANISM; GINKGO BILOBA; HUMAN; LETTER; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; RISK FACTOR;

EID: 36048988792     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.05.011     Document Type: Letter

References (22)

1. Lippi G., Targher G., and Guidi G.C. Ginkgo biloba, inflammation and lipoprotein(a). Atherosclerosis 195 (2007) 417-418
2. Rodríguez M., Ringstad L., and Schäfer P. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Atherosclerosis 192 (2007) 438-444
3. Dangas G., Ambrose J., D'Agate D., et al. Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease. Am J Cardiol 83 (1999) 583-585
4. Silaste M.-L., Rantala M., Alfthan G., et al. Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a). Arterioscler Thromb Vasc Biol 24 (2004) 498-503
5. Tsimikas S., Lau H.K., Han K.-R., et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109 (2004) 3164-3170
6. Della Loggia R., Sosa S., Tubaro A., et al. Anti-inflammatory activity of some Ginkgo biloba constituents and of their phospholipid-complexes. Fitoterapia 67 (1996) 257-264
7. Chen J.-W., Chen Y.-H., Lin F.-Y., Chen Y.-L., and Lin S.-J. Ginkgo biloba extract inhibits tumor necrosis factor-α-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) 1559-1566
8. Ilieva I., Ohgami K., Shiratori K., et al. The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res 79 (2004) 181-187
9. Zhou Y.-H., Yu J.-P., Liu Y.-F., et al. Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-α, NF-κBp65, IL-6) in TNBS-induced colitis in rats. Mediators Inflamm 2006 (2006) 1-9
10. Lippi G., Braga V., Adami S., and Guidi G. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta 271 (1998) 79-87
11. Lippi G., and Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 40 (2003) 1-42
12. Ramharack R., Barkalow D., and Spahr M.A. Dominant negative effect of TGF-β1 and TNF-α on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 18 (1998) 984-990
13. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
14. Klebanoff S.J. Myeloperoxidase: friend and foe. J Leukoc Biol 77 (2005) 598-625
15. Nomoto K., Oguchi S., Watanabe I., Kushiro T., and Kanmatsuse K. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1. J Cardiol 42 (2003) 201-206
16. Kameda K., Matsunaga T., Abe N., et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. Eur Heart J 24 (2003) 2180-2185
17. Kong Y.-Z., Yu X., Tang J.-J., et al. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 178 (2005) 207-215
18. Nadra I., Mason J.C., Philippidis P., et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?. Circ Res 96 (2005) 1248-1256
19. Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., and Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost 95 (2006) 511-518
20. Rattazzi M., Faggin E., Bertipaglia B., and Pauletto P. Innate immunity and atherogenesis. Lupus 14 (2005) 747-751
21. Zhu C., Ying D., Zhou D., et al. Expression of TGF-beta1 in smooth muscle cells regulates endothelial progenitor cells migration and differentiation. J Surg Res 125 (2005) 151-156
22. Lotito S.B., Actis-Goretta L., Renart M.L., et al. Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem Biophys Res Commun 276 (2000) 945-951